Technical Articles

Inhibition of tumor growth

Targeted protein degradation therapy for BCL-XL: Selective inhibition of tumor growth and strategies to mitigate platelet toxicity

2026-01-19

BCL-XL is a crucial anti-apoptotic member of the B-cell lymphoma-2 (BCL-2) protein family, which is overexpressed in various tumor cells and promotes tumor cell survival and proliferation by inhibiting the apoptosis process.

View details

Cancer
BCL-XL/VHL PROTAC Kit
Inhibition of tumor growth
Platelet toxicity

Total 1

Go to